Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.;Lead Discovery Center GmbH
发明人:
Choidas, Axel,Klebl, Bert,Habenberger, Peter,Eickhoff, Jan,Thomas, Roman,Heuckmann, Johannes
申请号：
AU2012298483
公开号：
AU2012298483A1
申请日:
2012.08.22
申请国别(地区):
AU
年份:
2014
代理人:
摘要：
The present invention relates to a CDK9 inhibitor, especially a selective CDK9 inhibitor, for use in treating, ameliorating and/or preventing midline carcinoma. Also corresponding methods for treating, preventing or ameliorating midline carcinoma are subject of the present invention. Preferably, NUT midline carcinoma is treated with the CDK9 inhibitors in accordance with the present invention.
